BIAYA PENGOBATAN PASIEN KANKER PAYUDARA STADIUM AWAL YANG MENDAPATKAN KEMOTERAPI KOMBINASI 5- FLUOROURASIL, DOKSORUBISIN, SIKLOFOSFAMID (FAC) DENGAN KEMOTERAPI KOMBINASI BERBASIS TAXAN
Background: Cancer is an important problem in health and economics. It caused by high morbidity and mortality rate, bad prognosys and chemotherapy resistance which cause the number of cancer patient increase annually. Appropriate selection of combination chemotherapy has an important role to outcome...
Principais autores: | , |
---|---|
Formato: | Tese |
Publicado em: |
[Yogyakarta] : Universitas Gadjah Mada
2011
|
Assuntos: |